OptiNose Inc (OPTN)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
1.26
0.00 (0.00%)
After-Hours: 20:00
OptiNose Cash from Operations (Quarterly): -22.02M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -22.02M |
December 31, 2023 | 6.909M |
September 30, 2023 | -4.425M |
June 30, 2023 | -12.54M |
March 31, 2023 | -10.48M |
December 31, 2022 | -17.68M |
September 30, 2022 | -17.50M |
June 30, 2022 | -13.14M |
March 31, 2022 | -19.34M |
December 31, 2021 | -16.72M |
September 30, 2021 | -9.701M |
June 30, 2021 | -22.49M |
March 31, 2021 | -28.02M |
December 31, 2020 | -19.16M |
September 30, 2020 | -15.53M |
Date | Value |
---|---|
June 30, 2020 | -23.55M |
March 31, 2020 | -27.97M |
December 31, 2019 | -18.11M |
September 30, 2019 | -15.13M |
June 30, 2019 | -27.89M |
March 31, 2019 | -29.69M |
December 31, 2018 | -20.19M |
September 30, 2018 | -24.13M |
June 30, 2018 | -24.50M |
March 31, 2018 | -23.00M |
December 31, 2017 | -13.80M |
September 30, 2017 | -8.244M |
June 30, 2017 | -6.104M |
March 31, 2017 | -7.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.02M
Minimum
Mar 2021
6.909M
Maximum
Dec 2023
-16.72M
Average
-17.59M
Median
Cash from Operations (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | -149.16M |
Viking Therapeutics Inc | -6.134M |
Zevra Therapeutics Inc | -16.16M |
CytomX Therapeutics Inc | -26.04M |
Spero Therapeutics Inc | 5.938M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.022M |
Cash from Financing (Quarterly) | 0.007M |
Free Cash Flow | -32.43M |
Free Cash Flow Per Share (Quarterly) | -0.1958 |
Free Cash Flow to Equity (Quarterly) | -22.47M |
Free Cash Flow Yield | -22.92% |